Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Normal Renal Function”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01374113
What this trial is testing

Safinamide Renal Impairment Trial

Who this might be right for
Renal Impairment
Newron Pharmaceuticals SPA 24
Early research (Phase 1)Study completedNCT02172118
What this trial is testing

BI 1744 CL in Patients With Severe Renal Impairment in Comparison to Subjects With Normal Renal Function

Who this might be right for
Healthy
Boehringer Ingelheim 22
Early research (Phase 1)Study completedNCT02427035
What this trial is testing

CSL112 in Healthy Adults and in Adults With Moderate Renal Impairment

Who this might be right for
Acute Myocardial Infarction
CSL Behring 32
Early research (Phase 1)Study completedNCT01054261
What this trial is testing

To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.

Who this might be right for
Renal
VIVUS LLC 24
Early research (Phase 1)WithdrawnNCT02325024
What this trial is testing

Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.

Who this might be right for
Renal InsufficiencyKidney Disease
GW Pharmaceuticals Ltd
Early research (Phase 1)Study completedNCT00596518
What this trial is testing

Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function

Who this might be right for
Renal Insufficiency, Chronic
Pfizer 30
Early research (Phase 1)Study completedNCT00483860
What this trial is testing

A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function

Who this might be right for
Solid Tumours
GlaxoSmithKline 59
Early research (Phase 1)Study completedNCT05374343
What this trial is testing

The Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment

Who this might be right for
Type 2 Diabetes
Sunshine Lake Pharma Co., Ltd. 32
Early research (Phase 1)Ended earlyNCT01406340
What this trial is testing

Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Impairment

Who this might be right for
Anaemia
GlaxoSmithKline 22
Testing effectiveness (Phase 2)Study completedNCT03131479
What this trial is testing

Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function.

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 53
Early research (Phase 1)Study completedNCT03443063
What this trial is testing

Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment

Who this might be right for
Renal Impairment
Eisai Inc. 16
Early research (Phase 1)Study completedNCT05711381
What this trial is testing

Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function

Who this might be right for
Renal Impairment
Hanmi Pharmaceutical Company Limited 16
Early research (Phase 1)Study completedNCT03961932
What this trial is testing

Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function

Who this might be right for
Renal ImpairmentHealthy Participants
ObsEva SA 33
Early research (Phase 1)Study completedNCT03844555
What this trial is testing

Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients

Who this might be right for
Renal ImpairmentRenal InsufficiencyKidney Diseases+1 more
Genfit 23
Early research (Phase 1)Study completedNCT01331941
What this trial is testing

A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

Who this might be right for
Advanced Solid TumorsKidney DiseaseRenal Impairment
Amgen 35
Early research (Phase 1)Study completedNCT00501462
What this trial is testing

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2Renal Insufficiency
GlaxoSmithKline 29
Early research (Phase 1)Ended earlyNCT01675973
What this trial is testing

Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine

Who this might be right for
Severe Renal Impairment
Gilead Sciences 4
Early research (Phase 1)UnknownNCT05947097
What this trial is testing

Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Haisco Pharmaceutical Group Co., Ltd. 32
Not applicableUnknownNCT06106126
What this trial is testing

Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Renal Function

Who this might be right for
COVID-19 Pneumonia
Fujian Akeylink Biotechnology Co., Ltd. 32
Early research (Phase 1)Study completedNCT04476849
What this trial is testing

Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal Function

Who this might be right for
Healthy VolunteersRenal Impairment
Astellas Pharma Global Development, Inc. 27
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation